Idorsia Ltd Sustainability Reports
Idorsia Ltd is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small molecule therapeutics to meet significant unmet medical needs. Its clinical development pipeline covers therapeutic areas such as central nervous system disorders, cardiovascular disorders, immunological disorders, and orphan diseases.
Sector: Manufacturing
Country: Switzerland
Exchange: SIX Swiss Exchange
LEI: 506700XOVZUB107S5720
FIGI: BBG00FXVZB35
14 reports from 2019 to 2025
